American Journal of Cardiology
Volume 105, Issue 2 , Pages 255-260 , 15 January 2010

Adherence to Guideline-Recommended Adjunctive Heart Failure Therapies Among Outpatient Cardiology Practices (Findings from IMPROVE HF)

  • Clyde W. Yancy, MD

      Affiliations

    • Baylor Heart and Vascular Institute, Baylor University Medical Center, Dallas, Texas
    • Corresponding Author InformationCorresponding author: Tel: 214-820-7357; fax: 214-820-7533
  • ,
  • Gregg C. Fonarow, MD

      Affiliations

    • Department of Medicine, University of California, Los Angeles, Medical Center, Los Angeles, California
  • ,
  • Nancy M. Albert, PhD, RN

      Affiliations

    • George M. and Linda H. Kaufman Center for Heart Failure, Cleveland Clinic Foundation, Cleveland, Ohio
  • ,
  • Anne B. Curtis, MD

      Affiliations

    • Division of Cardiology, University of South Florida College of Medicine, Tampa, Florida
  • ,
  • Wendy Gattis Stough, PharmD

      Affiliations

    • Department of Clinical Research, Campbell University School of Pharmacy, Research Triangle Park, North Carolina
    • Department of Medicine, Duke University Medical Center, Durham, North Carolina
  • ,
  • Mihai Gheorghiade, MD

      Affiliations

    • Division of Cardiology, Northwestern University, Feinberg School of Medicine, Chicago, Illinois
  • ,
  • J. Thomas Heywood, MD

      Affiliations

    • Division of Cardiology, Scripps Clinic, La Jolla, California
  • ,
  • Mark L. McBride, PhD

      Affiliations

    • Outcome Sciences, Inc., Cambridge, Massachusetts
  • ,
  • Mandeep R. Mehra, MD

      Affiliations

    • Division of Cardiology, University of Maryland, Baltimore, Maryland
  • ,
  • Christopher M. O'Connor, MD

      Affiliations

    • Division of Cardiology, Duke University Medical Center, Durham, North Carolina
  • ,
  • Dwight Reynolds, MD

      Affiliations

    • Cardiovascular Section, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma
  • ,
  • Mary Norine Walsh, MD

      Affiliations

    • The Care Group, LLC, Indianapolis, Indiana

Received 31 July 2009 ,Revised 25 August 2009 ,Accepted 25 August 2009.

References 

  1. Adams KF, Lindenfeld J, Arnold JMO, Baker DW, Barnard DH, Baughman KL, et al. HFSA 2006 comprehensive heart failure practice guideline. J Card Fail. 2006;12(suppl):e1–e122
  2. Rosendorff C, Black HR, Cannon CP, Gersh BJ, Gore J, Izzo JL J, et al. Treatment of hypertension on the prevention and management of ischemic heart disease: a scientific statement from the American Heart Association council for high blood pressure research and the councils on clinical cardiology and epidemiology and prevention. Circulation. 2007;115:2761–2788
  3. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, et al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (writing committee to update the 2001 guidelines for the evaluation and management of heart failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation. 2005;112(suppl):e154–e235
  4. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, et al. 2009 Focused update incorporated into the ACC/AHA 2005 guideline for the diagnosis and management of chronic heart failure in adults: a report of the American College of Cardiology/American Heart Association task force on practice guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation. 2009;119(suppl):e391–e479
  5. Fonarow GC, Yancy CW, Heywood JT ADHERE Scientific Advisory Committee, Study Group, and Investigators. Adherence to heart failure quality-of-care indicators in US hospitals: analysis of the ADHERE registry. Arch Intern Med. 2005;165:1469–1477
  6. Yancy CW, Abraham WT, Albert NM, Clare R, Stough WG, Gheorghiade M, et al. Quality of care and outcomes for African Americans hospitalized with heart failure: findings from the OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure) registry. J Am Coll Cardiol. 2008;51:1675–1684
  7. Kamath SA, Drazner MH, Wynne J, Fonarow GC, Yancy CW. Characteristics and outcomes in African American patients with decompensated heart failure. Arch Intern Med. 2008;168:1152–1158
  8. Yancy CW, Fonarow GC, Albert NM, Curtis AB, Stough WG, Gheorghiade M, et al. Influence of patient age and sex on delivery of guideline-recommended heart failure care in the outpatient cardiology practice setting: findings from IMPROVE HF. Am Heart J. 2009;157:754–762
  9. Fonarow GC, Yancy CW, Albert NM, Curtis AB, Stough GW, Gheorghiade M, et al. Heart failure care in the outpatient cardiology practice setting: findings from IMPROVE HF. Circ Heart Fail. 2008;1:98–106
  10. Nicol ED, Fittall B, Roughton M, Cleland JG, Dargie H, Cowie MR. NHS heart failure survey: a survey of acute heart failure admissions in England, Wales and Northern Ireland. Heart. 2008;94:172–177
  11. Lee DS, Tu JV, Juurlink DN, Alter DA, Ko DT, Austin PC, et al. Risk-treatment mismatch in the pharmacotherapy of heart failure. JAMA. 2005;294:1240–1247
  12. Fonarow GC, Yancy CW, Albert NM, Curtis AB, Stough WG, Gheorghiade M, et al. Improving the use of evidence-based heart failure therapies in the outpatient setting: the IMPROVE HF performance improvement registry. Am Heart J. 2007;154:12–38
  13. Taylor AL, Ziesche S, Yancy C, Carson P, D'Agostino R, Ferdinand K, et al. Combination of isosorbide dinitrate and hydralazine in blacks with heart failure. N Engl J Med. 2004;351:2049–2057
  14. Fonarow GC. Strategies to improve the use of evidence-based heart failure therapies: OPTIMIZE-HF. Rev Cardiovasc Med. 2004;5(suppl 1):S45–S54
  15. Yancy CW. Race-based therapeutics. Curr Hypertens Rep. 2008;10:276–285
  16. Moser M. Hypertension treatment and the prevention of coronary heart disease in the elderly. Am Fam Phys. 1999;59:1248–1256http://www.aafp.org/afp/990301ap/1248.htmlAccessed: March 10, 2009
  17. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)). JAMA. 2002;288:2981–2997
  18. Fonarow GC. Randomized clinical outcome trials of statins in heart failure. Heart Fail Clin. 2008;4:225–229
  19. Kjekshus J, Apetrei E, Barrios V, Böhm M, Cleland JG, Cornel JH, et al. Rosuvastatin in older patients with systolic heart failure. N Engl J Med. 2007;357:2248–2261
  20. Tavazzi L, Maggioni AP, Marchioli R, Barlera S, Franzosi MG, Latini R, et al. Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet. 2008;372:1231–1239
  21. Massie M. Aspirin use in chronic heart failure: what should we recommend to the practitioner?. J Am Coll Cardiol. 2005;46:963–966
  22. Cleland JG, Bulpitt CJ, Falk RH, Findlay IN, Oakley CM, Murray G, et al. Is aspirin safe for patients with heart failure?. Br Heart J. 1995;74:215–219
  23. Antiplatelet Trialists' Collaboration. Secondary prevention of vascular disease by prolonged antiplatelet treatment. Br Med J (Clin Res Ed). 1988;296:320–331
  24. Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy—I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Br Med J. 1994;308:81–106

 The IMPROVE HF registry and this study are sponsored by Medtronic, Inc., Minneapolis, Minnesota.

PII: S0002-9149(09)02335-2

doi: 10.1016/j.amjcard.2009.08.681

American Journal of Cardiology
Volume 105, Issue 2 , Pages 255-260 , 15 January 2010